Antigen targets of remission-inducing immune therapy are expressed on CML progenitor cells

le Biernacki, Melinda A., Marina, Ovidiu, Zhang, Wandi, Liu, Fenglong, Bruns, Ingmar, Cai, Ann, Neuberg, Donna, Canning, Christine M., Alyea, Edwin P., Soiffer, Robert J., Brusic, Vladimir, Ritz, Jerome, Wu, Catherine J.
Foilsithe 2010

Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid–immunoglobulin complexes in humans

le Lin, Yun, Zhang, Li, Cai, Ann X., Lee, Mark, Zhang, Wandi, Neuberg, Donna, Canning, Christine M., Soiffer, Robert J., Alyea, Edwin P., Ritz, Jerome, Hacohen, Nir, Means, Terry K., Wu, Catherine J.
Foilsithe 2011

Mutated BCR-ABL Generates Immunogenic T Cell Epitopes In CML Patients

le Cai, Ann, Keskin, Derin B., DeLuca, David S., Alonso, Anselmo, Zhang, Wandi, Zhang, Guang Lan, Hammond, Naa Norkor, Nardi, Valentina, Stone, Richard M., Neuberg, Donna, Sidney, John, Brusic, Vladimir, Wu, Catherine J.
Foilsithe 2012

Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include non-mutated B cell antigens

le Marina, Ovidiu, Hainz, Ursula, Biernacki, Melinda A., Zhang, Wandi, Cai, Ann, Duke-Cohan, Jonathan S., Liu, Fenglong, Brusic, Vladimir, Neuberg, Donna, Kutok, Jeffery L., Alyea, Edwin P., Canning, Christine M., Soiffer, Robert J., Ritz, Jerome, Wu, Catherine J.
Foilsithe 2010

Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α

le Shealy, David, Cai, Ann, Staquet, Kim, Baker, Audrey, Lacy, Eilyn R, Johns, Laura, Vafa, Omid, Gunn, George, Tam, Susan, Sague, Sarah, Wang, Dana, Brigham-Burke, Mike, Dalmonte, Paul, Emmell, Eva, Pikounis, Bill, Bugelski, Peter J, Zhou, Honghui, Scallon, Bernard, Giles-Komar, Jill
Foilsithe 2010